BioUtah Featured Member

ACADIA PHARMACEUTICALS

Membership Level: Elite Gold

For more than 25 years, Acadia has been trailblazing breakthroughs for people with neurological conditions. They developed and commercialized the first and only approved treatment for hallucinations and delusions associated with Parkinson’s disease psychosis, Nuplazid, and this is only the beginning of their work.

Headquartered in San Diego, Acadia also has research facilities in New Jersey. BioUtah extends a hearty welcome to Acadia as a new Elite Gold Level Member!